WEBINARS
Welcome to the Webinars section of the R3i Foundation! Here, we provide a platform for knowledge exchange and discussion on critical topics related to vascular health and residual risk. Our webinars feature esteemed experts from around the world who share their insights, research, and innovative strategies aimed at advancing our understanding and management of vascular conditions. By participating, you will gain access to valuable information, learn about the latest research developments, and engage with thought leaders in the field. Explore our upcoming webinars and access recordings of past sessions to stay informed and engaged.
2024
Pemafibrate to Treat and Prevent Diabetic Foot Ulceration: An Unmet Clinical Need Requiring Formal Evaluation
2024
Pr. Paul Ridker
This video delves into the critical management of diabetic foot ulcers and the potential role of pemafibrate in addressing this pressing health concern. With insights from leading experts, it discusses the current treatment limitations and the urgent need for formal evaluations of pemafibrate’s efficacy. Don’t miss the opportunity to enhance your understanding of this vital topic and how it may shape future diabetes care. Watch now!
Recent Advances in Pharmacotherapy of Diabetic Retinopathy in type 2 Diabetes Mellitus: PPARɑ agonists
2024
Pr. Alberto Zambon
This video presentation focuses on the significant role of PPARɑ agonists in treating diabetic retinopathy, exploring their mechanisms of action, clinical efficacy, and potential benefits for patients. Discover the latest findings and insights that can help redefine the therapeutic landscape for diabetic retinopathy.
More webinars
ACCORD Study Webinar
2014
Pr. Michel Hermans
The ACCORD trial, or Action to Control risks in patients with type 2 diabetes. Its aim was to compare the effects of different strategies on lowering blood sugar levels and their impact on cardiovascular outcomes. The trial involved multiple interventions, including intensive glucose control, blood pressure management, and cholesterol reduction. Key findings indicated that while intensive glucose control led to better hemoglobin A1c levels, it did not significantly reduce the risk of major cardiovascular events.
FIELD Study Webinar
2013
Pr. Michel Hermans
The webinar on the FIELD study discusses its objectives and findings related to residual vascular risk. It highlights the study’s significance in defining future vascular strategies and its focus on understanding the underlying factors contributing to residual risk.
